<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04308759</url>
  </required_header>
  <id_info>
    <org_study_id>RG1006844</org_study_id>
    <secondary_id>NCI-2020-00136</secondary_id>
    <secondary_id>RG1006844</secondary_id>
    <secondary_id>P30CA015704</secondary_id>
    <secondary_id>R01CA247156</secondary_id>
    <nct_id>NCT04308759</nct_id>
  </id_info>
  <brief_title>An Innovative Conversational Agent (Quitbot) for Smoking Cessation</brief_title>
  <official_title>Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase III trial compares two remote digital smoking cessation programs to see how well
      they work for quitting smoking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OUTLINE: Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day
      quit smoking program.

      GROUP I: Quitbot program, which involves prompted and focused conversations for 42 days.

      GROUP II: Texting program, which involves quit smoking messages for 42 days. After the
      completion of study, patients are followed up at 3, 6, and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with 30-day biochemically confirmed cigarette smoking cessation</measure>
    <time_frame>At 12 months after randomization</time_frame>
    <description>No smoking at all in the past 30 or more days. Will measure expired carbon monoxide (CO) by using the CO monitor Bedfont iCO Smokerlyzer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with 30-day biochemically confirmed cigarette smoking cessation</measure>
    <time_frame>At 3 and 6 months after randomization</time_frame>
    <description>No smoking at all in the past 30 or more days. Will measure expired carbon monoxide (CO) by using the CO monitor Bedfont iCO Smokerlyzer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1520</enrollment>
  <condition>Cigarette Smoking-Related Carcinoma</condition>
  <arm_group>
    <arm_group_label>Group I (Quitbot)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants participate in the Quitbot program which involves prompted, focused conversations for 42 days. Therapy description withheld to protect the integrity of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (Texting)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants participate in texting program over 42 days where they receive messages to support quitting smoking. Therapy description withheld to protect the integrity of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>QuitBot Smoking Cessation Program</intervention_name>
    <description>Participate in Quitbot experimental cessation program</description>
    <arm_group_label>Group I (Quitbot)</arm_group_label>
    <other_name>QuitBot</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Texting Smoking Cessation Program</intervention_name>
    <description>Participate in Texting program</description>
    <arm_group_label>Group II (Texting)</arm_group_label>
    <other_name>Texting</other_name>
    <other_name>Text</other_name>
    <other_name>Texting program</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Smokes at least one cigarette a day for the past 12 months

          -  Wants to quit cigarette smoking within the next 30 days (consistent with text
             messaging intervention trials)

          -  If concurrently using any other nicotine or tobacco products, wants to quit using them
             within the next 30 days

          -  Interested in learning skills to quit smoking

          -  Willing to be randomly assigned to either intervention

          -  Resides in United States (US) and will continue to reside in the US for the next 12
             months

          -  Has at least daily access to their own smartphone

          -  Has both text messaging and Facebook messenger (FM) on their smartphone

          -  Willing and able to read in English, and

          -  Not using other smoking cessation interventions. (This eligibility requirement helps
             ensure results are due to the treatments we recommend rather than those that
             participants are doing on their own).

        Exclusion Criteria:

          -  The reverse of the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan B Bricker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fred Hutch/University of Washington Cancer Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brie Sullivan</last_name>
    <phone>206-667-5238</phone>
    <email>bsulliva@fredhutch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fred Hutch/University of Washington Cancer Consortium</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Brie Sullivan</last_name>
      <phone>206-667-5238</phone>
      <email>bsulliva@fredhutch.org</email>
    </contact>
    <investigator>
      <last_name>Jonathan B. Bricker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 6, 2020</study_first_submitted>
  <study_first_submitted_qc>March 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2020</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>quitting smoking</keyword>
  <keyword>chatbot</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

